Pasithea Therapeutics stockholders elect Dr. Emer Leahy as Class I director; ratify Marcum LLP as auditor

Pasithea Therapeutics Corp.

Dr. Emer Leahy elected as Class I director with 227,198 for, 27,223 withheld, 115,196 broker non-votes.
Ratification of Marcum LLP as independent auditor approved: 333,986 for, 34,177 against, 1,454 abstain.
Annual Meeting held June 26, 2024; quorum of 369,617 shares of 1,043,248 outstanding shares represented.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.